دورية أكاديمية
Efficacy of Various Interventions for Achieving Target HbA1C Levels for Patients with Type II Diabetes Mellitus and on Exogenous Insulin
| العنوان: | Efficacy of Various Interventions for Achieving Target HbA1C Levels for Patients with Type II Diabetes Mellitus and on Exogenous Insulin |
|---|---|
| المؤلفون: | Welch, Caitlin S, Troxel, Archie |
| المصدر: | Longitudinal Scholar's Project |
| بيانات النشر: | UTHSC Digital Commons |
| سنة النشر: | 2022 |
| المجموعة: | UTHSC Digital Commons (University of Tennessee Health Science Center) |
| مصطلحات موضوعية: | T2DM, type II diabetes mellitus, diabetes, HbA1C, hemoglobin A1C, insulin, metformin, SGLT2 inhibitors, sodium glucose co-transporter 2 inhibitor, GLP1RA, glucagon like peptide 1 receptor antagonist, diabetes control, diabetics on insulin, type 2 diabetes interventions, Analytical, Diagnostic and Therapeutic Techniques and Equipment, Diseases, Endocrine System Diseases, Endocrinology, and Metabolism, Family Medicine, Health and Medical Administration, Health Services Administration, Health Services Research, Investigative Techniques, Medical Education, Medicine and Health Sciences, Nutritional and Metabolic Diseases, Quality Improvement, Therapeutics |
| الوصف: | Objective: To learn the rates at which patients at UT Family Medicine–St. Francis (UTFM–SF) with type II diabetes mellitus are being prescribed recommended medications—namely metformin, sodium-glucose cotransporter 2 (SGLT2) inhibitors, and glucagon-like peptide 1 receptor agonists (GLP1RAs)—whether these rates correspond to the severity of hyperglycemia (as indicated by HbA1C level). A secondary goal of the study was to investigate if HbA1C levels are being checked at recommended intervals. Methods: A retrospective chart review was conducted using records of patients seen at the clinic in the previous four years between the ages of 18 and 65 who had visits with ICD 10 codes for type II diabetes mellitus (E11) and long term insulin use (Z79.4). Patients with an HbA1C result from January 1, 2018 or later and a chart history of an insulin prescription were selected for further analysis. Results: 234 patients met the search criteria and were divided into three groups based on an average of the three most recent HbA1C labs: Below the American Diabetes Association (ADA) recommended HbA1C of 7% (n=40), between 7% and the insurance quality metric goal of 9% (n=66), and above 9% (n=128). A chi-square test revealed there was no significant association between HbA1C group and the rate of prescription of metformin (2-sided, p=.631), SGLT2 inhibitors (P=.221), or GLP1RAs (P=.223); a chi-square test also showed there was no association between group and the number of medications prescribed (P=.236). A one-way ANOVA revealed no statistically significant differences between group with regards to frequency of HbA1C checks (P=.295). Conclusion: Patients at UTFM–SF with lower levels of glycemic control are not receiving significantly different treatment from patients who demonstrate better glycemic control—they are not being prescribed recommended medication classes at a different rate, they are not having medications combined at a different rate, and their HbA1Cs are not being monitored differently. Increased utilization of ... |
| نوع الوثيقة: | text |
| وصف الملف: | application/pdf |
| اللغة: | unknown |
| العلاقة: | https://dc.uthsc.edu/lsp/21Test; https://dc.uthsc.edu/cgi/viewcontent.cgi?article=1020&context=lspTest |
| الإتاحة: | https://dc.uthsc.edu/lsp/21Test https://dc.uthsc.edu/cgi/viewcontent.cgi?article=1020&context=lspTest |
| رقم الانضمام: | edsbas.A02E2BC7 |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |